Company intelligence / Profile preview

WaveGuide

Waltham, Massachusetts, United Stateswaveguide.com ↗

Ownership: Private
Development stage: Commercial

Overview

The µNMR device has demonstrated rapid on-site analysis capabilities for various sample types. It enables early cancer detection and authenticity testing for vaccines/medicines. Some applications have received FDA predicate approval.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Notable collaboration with Cambridge Consultants on product developmentAT&T Business provides IoT connectivity solutions

Beyond the preview

Go deeper on WaveGuide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WaveGuide.

Explore the full profile